News | November 10, 2010

GE Highlights its Advances in Nuclear Imaging at RSNA

November 10, 2010 – During RSNA 2010, GE Healthcare will announce the availability of the Discovery NM/CT 670, an advanced hybrid imaging platform designed to improve workflow, dose management and overall image quality. The system combines a newly designed single photon emission computed tomography (SPECT) gantry for greater positional flexibility, advanced nuclear imaging detectors and GE’s BrightSpeed Elite 16-slice CT.

The Discovery PET/CT 600 series positron emission tomography/computed tomography (PET/CT) continues to expand with the Discovery PET/CT 690 with BrightSpeed Elite CT, which provides advanced imaging and applications capabilities, helping to enhance imaging quality and diagnostic confidence.

GE is also introducing a new tri-modality preclinical imaging system called the Triumph ll. The solid state digital imaging system has been upgraded to offer enhanced image quality, and quantitative capabilities, a wider bore size to fit larger animals, higher PET sensitivity, and new SPECT collimators for improved resolution and sensitivity.

Several technologies will be highlighted that improve dose management, increase efficiency and reduce exam times. This includes the technique of adaptive statistical iterative reconstruction (ASIR), which helps reduce CT dose by up to 50 percent across the Discovery PET/CT 600 series platform and Discovery NM/CT 570c. With GE’s Alycone technology, available on Discovery NM 530c and Discovery NM 570c, clinicians are able to gather image data more quickly and allow up to a fourfold decrease in either imagi g time or injected patient dose.

GE’s SharpIR, a sophisticated iterative reconstruction enhancement to VUE Point HD and VUE Point FX, is offered across the Discovery PET/CT 600 series platform to enhance visual contrast and resolution in both whole-body and brain PET images.

A recent addition to the Tracercenter CMP platform is the Tracercenter 710S, a new cost effective upgradeable solution for customers establishing their own infrastructure platform for radiotracer research, production or distribution and produces tracers for oncology.

For more information: www.gehealthcare.com

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
Nuclear imaging scan showing very good tissue delineation. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Nuclear imaging scan showing very good tissue delineation. It offers crisp overall image quality and sharply delineates the muscle and fat planes, vertebral margins and end plates, billiary radicals, renal calyces, aortic wall and papillary muscles of the heart. Scan performed on a Biograph Vision positron emission tomography/computed tomography (PET-CT) system from Siemens Healthineers.

Technology | PET-CT | June 05, 2018
June 5, 2018 — The U.S.
Overlay Init